Biden says biggest vaccine donation ‘supercharges’ battle against coronavirus

By Steve Holland

CARBIS BAY, England (Reuters) – U.S. President Joe Biden said on Thursday that a donation of 500 million doses of the Pfizer COVID-19 vaccine to the world’s poorest countries would supercharge the battle with the virus and comes with “no strings attached.”

Biden, speaking alongside Pfizer Chief Executive Albert Bourla in the English seaside resort of Carbis Bay ahead of a G7 summit, thanked other leaders for recognizing their responsibility to vaccinate the world.

“The United States is providing these half billion doses with no strings attached. No strings attached,” Biden said. “Our vaccine donations don’t include pressure for favors, or potential concessions. We’re doing this to save lives.”

Biden, keen to burnish his multilateral credentials on his first foreign trip as leader, cast the donation as a bold move that showed America recognized its responsibility to the world and to its own citizens.

“America will be the arsenal of vaccines in our fight against COVID-19, just as America was the arsenal of democracy during World War Two,” Biden said.

The largest ever vaccine donation by a single country will cost the United States $3.5 billion but will spur further donations from other G7 leaders – including British Prime Minister Boris Johnson.

G7 leaders want to vaccinate the world by the end of 2022 to try to halt the COVID-19 pandemic that has killed more than 3.9 million people, devastated the global economy and upended the normal lives of billions of people.

Vaccination efforts so far are heavily correlated with wealth: the United States, Europe, Israel and Bahrain are far ahead of other countries. A total of 2.2 billion people have been vaccinated so far out of a world population of nearly 8 billion, based on Johns Hopkins University data.

‘SAVE LIVES’

U.S. drugmaker Pfizer and its German partner BioNTech have agreed to supply the U.S. with the vaccines, delivering 200 million doses in 2021 and 300 million doses in the first half of 2022.

The shots, which will be produced at Pfizer’s U.S. sites, will be supplied at a not-for-profit price. Around 100 countries will get the shots.

Pfizer CEO Bourla said the eyes of the world were on the leaders of rich nations to see if they would act to solve the COVID-19 crisis and share with poorer nations.

“This announcement with the U.S. government gets us closer to our goal and significantly enhances our ability to save even more lives across the globe,” he said.

While such a large donation of vaccines was welcomed by many, there were immediately calls for the richest nations of the world to open up more of their giant hoards of vaccines.

Anti-poverty campaign group Oxfam called for more to be done to increase global production of vaccines.

“Surely, these 500 million vaccine doses are welcome as they will help more than 250 million people, but that’s still a drop in the bucket compared to the need across the world,” said Niko Lusiani, Oxfam America’s vaccine lead.

“We need a transformation toward more distributed vaccine manufacturing so that qualified producers worldwide can produce billions more low-cost doses on their own terms, without intellectual property constraints,” he said in a statement.

Another issue, especially in some poor countries, is the infrastructure for transporting the vaccines which often have to be stored at very cold temperatures.

IP WAIVER

Biden has also backed calls for a waiver of some vaccine intellectual property rights but there is no international consensus yet on how to proceed.

The new vaccine donations come on top of 80 million doses Washington has already pledged to donate by the end of June. There is also $2 billion in funding earmarked for the COVAX program led by the World Health Organization (WHO) and the Global Alliance for Vaccines and Immunization (GAVI), the White House said.

GAVI and the WHO welcomed the initiative.

Washington is also taking steps to support local production of COVID-19 vaccines in other countries, including through its Quad initiative with Japan, India and Australia.

(Reporting by Steve Holland in St. Ives, England, Andrea Shalal in Washington and Caroline Copley in Berlin; Writing by Guy Faulconbridge and Keith Weir; Editing by Leslie Adler, David Evans, Emelia Sithole-Matarise, Giles Elgood, Jane Merriman and Marguerita Choy)

Canada authorizes Pfizer COVID-19 vaccine for children aged 12 to 15

TORONTO (Reuters) -Canada is authorizing the use of Pfizer Inc’s COVID-19 vaccine for use in children from 12 to 15, the first dose to be allowed for people that young, the federal health ministry said on Wednesday.

“The department determined that this vaccine is safe and effective when used in this younger age group,” Supriya Sharma, a senior adviser at the ministry, told a briefing. “We are starting to see the light at the end of the tunnel.”

Canada’s federal government has bought tens of millions of doses of vaccines but critics complain the pace of inoculation is lagging amid bottlenecks in the 10 provinces, which are responsible for administering the doses.

Sharma said Pfizer, which is working with German partner BioNTech SE, would be required to provide information on the safety, efficacy and quality of the vaccine in the 12 to 15 age group.

Around 20% of the 1,249,950 cases of COVID-19 in Canada have been reported in people under the age of 19. Canada has also recorded 24,396 deaths.

(Reporting by Allison Martell in Toronto and David Ljunggren in Ottawa, Editing by Chizu Nomiyama)